Association of MTHFR and PPARγ2 gene polymorphisms in relation to type 2 diabetes mellitus cases among north Indian population.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Gene

• Publication date

  2012-12-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.gene.2012.09.072PMID 23036708
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Methylene Tetrahydrofolate Reductase Gene Polymorphism and the Risk of Ischemic Stroke in Type 2 Diabetic Egyptian Patients

  2011cited by this paper
• Methylenetetrahydrofolate reductase gene polymorphism in diabetes and obesity

  2009cited by this paper
• Polymorphism of the methylenetetrahydrofolate reductase gene association with homocysteine and ischemic stroke in type 2 diabetes.

  2009cited by this paper
• Homocysteine status and acute myocardial infarction among Tamilians

  2008cited by this paper
• The association between ACE gene I/D polymorphism and type 2 diabetes in Han Chinese in Hubei.

  2008cited by this paper
• MTHFR C677T and A1298C gene polymorphisms and hyperhomocysteinemia as risk factors of diabetic nephropathy in type 2 diabetes patients.

  2007cited by this paper
• Obesity, Peroxisome Proliferator-Activated Receptor, and Atherosclerosis in Type 2 Diabetes

  2006cited by this paper
• Effect of polymorphisms of the MTHFR and APOE genes on susceptibility to diabetes and severity of diabetic retinopathy in Brazilian patients.

  2006cited by this paper
• Implication of the Pro12Ala polymorphism of the PPAR-gamma 2 gene in type 2 diabetes and obesity in the French population

  2005cited by this paper
• The peroxisome proliferator activated receptorφ2 (PPARφ2) Pro12Ala variant: lack of association with type 2 diabetes in obese and non obese Tunisian patients

  2005cited by this paper
• The peroxisome proliferator activated receptorgamma2 (PPARgamma2) Pro12Ala variant: lack of association with type 2 diabetes in obese and non obese Tunisian patients.

  2005cited by this paper
• Metabolism of Homocysteine and its Relationship with Cardiovascular Disease

  2004cited by this paper
• Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.

  2004cited by this paper
• Methylene tetrahydrofolate reductase C677T mutation and left ventricular hypertrophy in Turkish patients with type II diabetes mellitus.

  2004cited by this paper
• A functional variant in the peroxisome proliferator-activated receptor gamma2 promoter is associated with predictors of obesity and type 2 diabetes in Pima Indians.

  2003cited by this paper
• Plasmatic homocysteine concentration and its relationship with complications associated to diabetes mellitus.

  2002cited by this paper
• Total homocysteine and cognitive deterioration in people with type 2 diabetes.

  2002cited by this paper
• Association between homocysteinemia and renal function in patients with type 2 diabetes mellitus.

  2002cited by this paper
• The Pro12 -->Ala substitution in PPAR-gamma is associated with resistance to development of diabetes in the general population: possible involvement in impairment of insulin secretion in individuals with type 2 diabetes.

  2001cited by this paper
• Homocysteine in health and disease

  2001cited by this paper
• Homocysteine and cardiovascular disease in diabetes mellitus.

  2001cited by this paper
• Relation between homocysteinaemia and diabetic neuropathy in patients with Type 2 diabetes mellitus

  2001cited by this paper
• Association between high homocyst(e)ine and ischemic stroke due to large- and small-artery disease but not other etiologic subtypes of ischemic stroke.

  2000cited by this paper
• MTHFR gene polymorphism as an exacerbation factor of diabetic nephropathy in type 2 diabetes. Analysis in Japanese male hemodialysis patients.

  2000cited by this paper
• The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes

  2000cited by this paper
• Inhibitory effect of a proline-to-alanine substitution at codon 12 of peroxisome proliferator-activated receptor-gamma 2 on thiazolidinedione-induced adipogenesis.

  2000cited by this paper
• The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes.

  2000cited by this paper
• Homocysteine and endogenous markers of renal function in type 2 diabetic patients without coronary heart disease.

  2000cited by this paper
• Homozygosity of the Pro12Ala variant of the peroxisome proliferation-activated receptor-γ2 (PPAR-γ2): divergent modulating effects on body mass index in obese and lean Caucasian men

  1999cited by this paper
• PPARγ, the ultimate thrifty gene

  1999cited by this paper
• PPARgamma, the ultimate thrifty gene.

  1999cited by this paper
• Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease?

  1998cited by this paper
• Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus: a population-based study.

  1998cited by this paper
• A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity

  1998cited by this paper
• Association of the Pro12Ala variant in the peroxisome proliferator-activated receptor-gamma2 gene with obesity in two Caucasian populations.

  1998cited by this paper
• Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPAR gamma) gene in diabetic Caucasians: identification of a Pro12Ala PPAR gamma 2 missense mutation.

  1997cited by this paper
• The Organization, Promoter Analysis, and Expression of the Human PPARγ Gene*

  1997cited by this paper
• Molecular Scanning of the Human Peroxisome Proliferator Activated Receptor γ (hPPARγ) Gene in Diabetic Caucasians: Identification of a Pro12Ala PPARγ2 Missense Mutation

  1997cited by this paper
• A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase

  1995cited by this paper
• Hyperhomocysteinemia and traditional cardiovascular disease risk factors in end-stage renal disease patients on dialysis: a case-control study.

  1995cited by this paper
• Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

  1972cited by this paper

• Genetic variability of the MTHFR rs1801133 gene polymorphism and role of zinc level in obese patients

  2025cites this paper
• The Implication of a Polymorphism in the Methylenetetrahydrofolate Reductase Gene in Homocysteine Metabolism and Related Civilisation Diseases

  2023cites this paper
• Role of polymorphisms of folate-cycle enzymes in diabetic retinopathy progression in patients with type 2 diabetic mellitus

  2022cites this paper
• Effect of MTHFR (rs1801133) and FTO (rs9939609) genetic polymorphisms and obesity in T2DM: a study among Bengalee Hindu caste population of West Bengal, India

  2021influential citation
• PPARG (Pro12Ala) genetic variant and risk of T2DM: a systematic review and meta-analysis

  2020cites this paper
• Association of CAPN10 (SNP-19) genetic polymorphism and obesity with T2DM: a study on Bengali Hindu caste population

  2020cites this paper
• The risk of T2DM with Alcohol consumption, Smoking, Hypertension and Family History of Hypertension: A Study on Bengalee Hindu Caste Population

  2020cites this paper
• Identification of the potential type 2 diabetes susceptibility genetic elements in South Asian populations

  2020cites this paper
• Molecular & biochemical analysis of Pro12Ala variant of PPAR-γ2 gene in type 2 diabetes mellitus

  2020cites this paper
• Determination of individual type 2 diabetes risk profile in the North East Indian population & its association with anthropometric parameters

  2019cites this paper
• Association of Two Methylenetetrahydrofolate Reductase Polymorphisms (rs1801133, rs1801131) with the Risk of Type 2 Diabetes in South-East of Iran.

  2019cites this paper
• Association between MTHFR variant and diabetic neuropathy

  2018cites this paper
• ANALYSIS OF THE METHYLENETETRAHYDROFOLATE REDUCTASE C 677 T GENE POLYMORPHISM AND SERUM LIPID LEVELS IN YOUNG INDIVIDUALS OF NORTHEAST MEXICO

  2018cites this paper
• Dynamics of Diabetes and Obesity: An Alarming Situation in the Developing Countries in Asia.

  2016cites this paper
• Study of PPARG 2 Gene Polymorphism ( Pro 12 Ala ) in Iraqi Patients with Type 2 Diabetes Mellitus

  2016cites this paper
• Association of JAZF1 and TSPAN8/LGR5 variants in relation to type 2 diabetes mellitus in a Saudi population

  2015cites this paper
• Evaluation of Gestational Diabetes Mellitus Risk in South Indian Women Based on MTHFR (C677T) and FVL (G1691A) Mutations

  2015cites this paper
• Implications of critical PPARγ2, ADIPOQ and FTO gene polymorphisms in type 2 diabetes and obesity-mediated susceptibility to type 2 diabetes in an Indian population

  2015cites this paper
• Does genetic heterogeneity account for the divergent risk of type 2 diabetes in South Asian and white European populations?

  2014cites this paper
• Adiponectin and peroxisome proliferator-activated receptor-γ gene polymorphisms and gene-gene interactions with type 2 diabetes.

  2014cites this paper
• Methylenetetrahydrofolate Reductase Gene Polymorphism and Risk of Type 2 Diabetes Mellitus

  2013cites this paper
• Association of Genetic polymorphism of PPARγ-2, ACE, MTHFR, FABP-2 and FTO genes in risk prediction of type 2 diabetes mellitus

  2013cites this paper